World's Best Scientists 2026 revealed!
Nicolaus Kröger

Nicolaus Kröger

D-Index & Metrics

Medicine

D-Index
115
Citations
46899
World Ranking
4562
National Ranking
247

Overview

Nicolaus Kröger is affiliated with Universität Hamburg in Germany and specializes in medicine, with a principal focus on hematology. Their research encompasses an extensive body of work in hematopoietic stem cell transplantation and related fields.

The main fields of study addressed in their publications include:

  • Medicine

The subfields they contribute to are:

  • Hematology
  • Oncology
  • Genetics
  • Public Health, Environmental and Occupational Health
  • Immunology

Nicolaus Kröger's research covers a range of specific topics, including:

  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • CAR-T Cell Therapy Research
  • Multiple Myeloma Research and Treatments

Some of the recent notable papers featuring Nicolaus Kröger's work are:

  • "Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN)", 2020, Journal of Clinical Oncology
  • "Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation", 2020, The Lancet Haematology
  • "Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years", 2021, Bone Marrow Transplantation
  • "Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)", 2021, Annals of Oncology
  • "Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022", 2022, Bone Marrow Transplantation

Frequent co-authors collaborating with Nicolaus Kröger include:

  • Mohamad Mohty
  • Ibrahim Yakoub-Agha
  • Arnon Nagler
  • Didier Blaise
  • Myriam Labopin

The venues where Nicolaus Kröger most often publishes are:

  • Bone Marrow Transplantation
  • Blood
  • Transplantation and Cellular Therapy
  • Haematologica
  • Blood Advances

Best Publications

  • Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

    Tiziano Barbui;Giovanni Barosi;Gunnar Birgegard;Francisco Cervantes

  • Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

    R A Kyle;B G M Durie;S V Rajkumar;O Landgren

  • Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

    R. Zeiser;A. Burchert;C. Lengerke;M.M. Verbeek

  • Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN)

    Andreas Burchert;Gesine Bug;Lea V. Fritz;Jürgen Finke

  • Antilymphocyte globulin for prevention of chronic graft-versus-host disease

    Nicolaus Kröger;Carlos Solano;Christine Wolschke;Giuseppe Bandini

  • Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

    Olaf Penack;Monia Marchetti;Tapani Ruutu;Mahmoud Aljurf

  • Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually

    Jakob Passweg;H. Baldomero;P. Bader;Chiara Bonini

  • Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

    Nicolaus Kröger;Ernst Holler;Guido Kobbe;Martin Bornhäuser

  • Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report

    Ayalew Tefferi;Francisco Cervantes;Ruben Mesa;Francesco Passamonti

  • Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report

    J R Passweg;H Baldomero;P Bader;C Bonini

  • Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

    T. Ruutu;A. Gratwohl;T. De Witte;B. Afanasyev

  • Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

    Jakob R. Passweg;Helen Baldomero;Christian Chabannon;Grzegorz W. Basak

  • Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

    Theo De Witte;David Bowen;Marie Robin;Luca Malcovati

  • Evidence of a Graft-Versus-Leukemia Effect in Chronic Lymphocytic Leukemia After Reduced-Intensity Conditioning and Allogeneic Stem-Cell Transplantation: The Cooperative German Transplant Study Group

    J. Schetelig;C. Thiede;M. Bornhäuser;R. Schwerdtfeger

  • Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia

    ZiYi Lim;Ronald Brand;Rodrigo Martino;Anja van Biezen

  • Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

    Ibrahim Yakoub-Agha;Christian Chabannon;Peter Bader;Grzegorz W. Basak

  • OUTCOME OF TRANSPLANTATION FOR MYELOFIBROSIS

    Karen K. Ballen;Smriti Shrestha;Kathleen A. Sobocinski;Mei Jie Zhang

  • Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

    Martin Bornhäuser;Joachim Kienast;Rudolf Trenschel;Andreas Burchert

  • Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group.

    N. M. Kröger;J. H. Deeg;E. Olavarria;D. Niederwieser

  • Treosulfan/fludarabine: a new conditioning regimen in allogeneic transplantation.

    J Casper;W Knauf;I Blau;T Ruutu

Frequent Co-Authors

Axel R. Zander
Axel R. Zander Huntsman Cancer Institute
Arnon Nagler
Arnon Nagler Sheba Medical Center
Jürgen Finke
Jürgen Finke University of Freiburg
Ibrahim Yakoub-Agha
Ibrahim Yakoub-Agha University of Lille
Dietger Niederwieser
Dietger Niederwieser Leipzig University
Jakob Passweg
Jakob Passweg University Hospital of Basel
Gérard Socié
Gérard Socié Université Paris Cité
Myriam Labopin
Myriam Labopin Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a future in Medicine doesn’t always mean attending medical school. There are a range of online degrees and career pathways designed to fast-track your entry into healthcare, or to help you specialize further. For example, if you are looking for administrative roles, online medical coding classes with financial aid offer a flexible and affordable way to build essential skills in medical billing and coding.

If becoming a registered nurse is your goal, you might want to explore absn programs that don't require teas. These accelerated nursing programs help students avoid extra entrance exams, making the application process less stressful.

For those interested in leadership or management roles in healthcare, consider enrolling in the best online healthcare administration degree programs. And, if you're a nurse looking to advance your qualifications, asn to nurse practitioner programs provide a clear path to specialized practice and higher earning potential.

Best Scientists Citing Nicolaus Kröger

Trending Scientists

Recently Published Articles